Abstract
Background
Patients with longstanding inflammatory bowel disease are at high risk of developing intestinal cancers. In this study, we aimed to elucidate the differences between intestinal cancers associated with ulcerative colitis and Crohn’s disease.
Methods
Intestinal cancers in ulcerative colitis and Crohn’s disease patients treated between 1983 and 2020 at 43 Japanese institutions were retrospectively analyzed..
Results
A total of 1505 intestinal cancers in 1189 ulcerative colitis and 316 Crohn’s disease patients were studied. Almost all of ulcerative colitis-associated cancers (99%) were in the colon and rectum, whereas half of Crohn’s disease-associated cancers (44%) were in the anus, with 11% in the small intestine. Ulcerative colitis-associated cancers were diagnosed more frequently by surveillance (67% vs. 25%, P < 0.0001) and at earlier stages (stages 0–1, 71% vs. 27%, P < 0.0001) compared with Crohn’s disease-associated cancers. Colorectal cancers associated with Crohn’s disease showed a significantly worse 5-year overall survival rate than those associated with ulcerative colitis (stage 2, 76% vs. 89%, P = 0.01, stage 3, 18% vs. 68%, P = 0.0009, and stage 4, 0% vs. 13%, P = 0.04). Surveillance correlated with earlier diagnoses for ulcerative colitis- and Crohn’s disease-associated intestinal cancers, whereas shorter intervals between endoscopic examinations correlated with an earlier cancer diagnosis in ulcerative colitis patients but not in Crohn’s disease patients.
Conclusions
The clinical and oncological features of ulcerative colitis- and Crohn’s disease-associated cancers were very different. Crohn’s disease-associated cancers were diagnosed at more advanced stages and were detected less frequently by surveillance. Additionally, they showed a significantly poorer prognosis.
Similar content being viewed by others
Data accessibility statement
The data underlying this article will be shared after all the analyses are completed on reasonable request to the corresponding author.
Abbreviations
- JSCCR:
-
Japanese Society for Cancer of the Colon and Rectum
- ACG:
-
American College of Gastroenterology
- IBD:
-
Inflammatory bowel disease
- UC:
-
Ulcerative colitis
- CD:
-
Chrohn’s disease
References
Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152:313-21.e2.
Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323:1228–33.
Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet (London, England). 1990;336:357–9.
Uchino M, Ikeuchi H, Hata K, et al. Changes in the rate of and trends in colectomy for ulcerative colitis during the era of biologics and calcineurin inhibitors based on a Japanese nationwide cohort study. Surg Today. 2019;49:1066–73.
Watanabe T, Ajioka Y, Mitsuyama K, et al. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology. 2016;151:1122–30.
Bye WA, Ma C, Nguyen TM, et al. Strategies for detecting colorectal cancer in patients with inflammatory bowel disease: a cochrane systematic review and meta-analysis. Am J Gastroenterol. 2018;113:1801–9.
Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohn's Colitis. 2017;11:649–670.
Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384–413.
Farraye FA, Odze RD, Eaden J, et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138:746–74, 774 e1–4; quiz e12–3.
Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59:666–89.
Cole EB, Shah Y, McLean LP, et al. Frequency of surveillance and impact of surveillance colonoscopies in patients with ulcerative colitis who developed colorectal cancer. Clin Colorectal Cancer. 2018;17:e289–92.
Ananthakrishnan AN, Cagan A, Cai T, et al. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2015;13:322-329.e1.
Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county. Minnesota Gastroenterol. 2006;130:1039–46.
Gillen CD, Andrews HA, Prior P, et al. Crohn’s disease and colorectal cancer. Gut. 1994;35:651–5.
Dossett LA, White LM, Welch DC, et al. Small bowel adenocarcinoma complicating Crohn’s disease: case series and review of the literature. Am Surg. 2007;73:1181–7.
Watanabe T, Konishi T, Kishimoto J, et al. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study. Inflamm Bowel Dis. 2011;17:802–8.
Olén O, Erichsen R, Sachs MC, et al. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study. The Lancet. 2020;395:123–31.
Sasaki H, Ikeuchi H, Bando T, et al. Clinicopathological characteristics of cancer associated with Crohn’s disease. Surg Today. 2017;47:35–41.
Olén O, Erichsen R, Sachs MC, et al. Colorectal cancer in Crohn’s disease: a Scandinavian population-based cohort study. Lancet Gastroenterol Hepatol. 2020;5:475–84.
Choi PM, Zelig MP. Similarity of colorectal cancer in Crohn’s disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut. 1994;35:950–4.
Arhi C, Askari A, Nachiappan S, et al. Stage at diagnosis and survival of colorectal cancer with or without underlying inflammatory bowel disease: a population-based study. J Crohns Colitis. 2021;15:375–82.
Japan Society for Cancer of the Colon and Rectum. Multi-institutional registry of large bowel cancer in Japan Vol. 33 Cases treated in 2007. 2018; Available from: http://www.jsccr.jp/registration/pdf/Vol_33.pdf.
Lutgens MW, Oldenburg B, Siersema PD, et al. Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer. 2009;101:1671–5.
Hata K, Anzai H, Ikeuchi H, et al. Surveillance colonoscopy for ulcerative colitis-associated colorectal cancer offers better overall survival in real-world surgically resected cases. Am J Gastroenterol. 2019;114:483–9.
Hata K, Ishihara S, Watanabe T. Successful surveillance colonoscopy for patients with ulcerative colitis after ileorectal anastomosis. J Crohns Colitis. 2015;9:937–8.
Higashi D, Katsuno H, Kimura H, et al. Current state of and problems related to cancer of the intestinal tract associated with Crohn’s disease in Japan. Anticancer Res. 2016;36:3761–6.
Lakatos PL, David G, Pandur T, et al. Risk of colorectal cancer and small bowel adenocarcinoma in Crohn’s disease: a population-based study from western Hungary 1977–2008. J Crohns Colitis. 2011;5:122–8.
Hata K, Ishihara S, Ajioka Y, et al. Long-term follow-up of targeted biopsy yield (LOFTY Study) in ulcerative colitis surveillance colonoscopy. J Clin Med. 2020;9:2286.
Acknowledgements
We thank all the involved doctors in the following institutions: Department of Inflammatory Bowel Disease Surgery, Hyogo College of Medicine; Department of Surgery, Keio University; Department of Surgery, Fukuoka University Chikushi Hospital; Department of Surgical Oncology, The University of Tokyo Hiroshima University Hospital; Department of Surgical Oncology, Osaka City University Graduate School of Medicine; Department of Surgery, Tohoku University Graduate School of Medicine; Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University; Department of Coloproctology, Tokyo Yamate Medical Center; Department of Gastrointestinal and Pediatric Surgery, Institute of Life Sciences, Mie University Graduate School of Medicine; Department of Gastroenterological Surgery, Graduate School of Medical, Osaka University; Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University; Department of Surgery, Coloproctology Center Takano Hospital; Division of Digestive and General Surgery, Graduate School of Medical and Dental Sciences, Niigata University; Department of Surgery, Toho University Sakura Medical Center; Inflammatory Bowel Disease Centre, Yokohama City University Medical Centre; Department of Colorectal Surgery, Tohoku Rosai Hospital; Department of Surgery, Kyoto University Hospital; Department of Gastrointestinal Surgery, Tokyo Medical and Dental University; Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University; Department of Surgery, Kindai University, Faculty of Medicine; Department of Surgery, Nara Medical University; Department of Surgery, National Defense Medical College; Inflammatory Bowel Disease Center, Yokkaichi Hazu Medical Center; Department of Surgery, Fujita Health University, School of Medicine; Inflammatory Bowel Disease Center, Sapporo Higashi Tokushukai Hospital; Center for Gastroenterology, Department of Surgery, Urasoe General Hospital; Department of Gastroenterological Surgery, Aichi Cancer Center Hospital; Department of Surgery, Kurume University Hospital; Department of Surgery, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo; Department of Gastroenterological Surgery, Saitama Medical University International Medical Center; Department of Surgery, Teikyo University School of Medicine; Department of Gastroenterological Surgery, Osaka City General Hospital; Kurume Coloproctology Center; Department of Surgery, Nishinomiya Municipal Central Hospital; Department of Coloproctological Surgery, Japanese Red Cross Medical Center; Department of Surgery, Osaka Rosai Hospital; Department of Surgery, Kyorin University; Department of Colorectal Surgery, National Cancer Center Hospital; Department of Surgery, Tokyo Medical University Hospital; Department of Gastroenterological Surgery, Nagoya University Hospital; Department of Surgery, National Center for Global Health and Medicine; Department of Surgery, Yamagata Prefectural Central Hospital; Division of Gastroenterological Surgery, Saitama Cancer Center; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School; Departments of Surgery, Faculty of Medical Sciences, University of Fukui; Department of Gastroenterological Surgery Tokai University School of Medicine. We also wish to thank Keisuke Hata for his advice on the study designs and analysis of the data.
Funding
This work was supported by the Japanese Society of Cancer of the Colon and Rectum.
Author information
Authors and Affiliations
Consortia
Contributions
SI is the chief investigator of this study group and the corresponding author; contributed to the design of the work, the analysis, and interpretation of data for the work; and revised the manuscript critically for important intellectual content. TN is the first author and contributed to the acquisition of data for the work, and drafted the work. KS and YA contributed to the conception of the work, and revised the work critically for important intellectual content. MU, HI, KO, KF, ST, HO, HN, KW, MI, KO, YT, TM, MN, KY, TW, YS, HK, KT, KH, YK, JO, KD, FK, HU, TY, TH, AM, and JA contributed to the acquisition of the data for the work, and revised the work critically for important intellectual content. KW, KH, JO, FK, HU, and AM contributed to the analysis of the data for the work, and revised the work critically for important intellectual content. HI, KF, ST, HO, KW, MI, YT, TM, MN, TW, KT, KH, YK, JO, KD, and KO contributed to the interpretation of the data for the work, and revised the work critically for important intellectual content. All the authors approved the final version to be published, and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The funding source had no role in study design, data collection, data analysis and interpretation, preparation of the manuscript, or decision to publish.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Noguchi, T., Ishihara, S., Uchino, M. et al. Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease. J Gastroenterol 58, 14–24 (2023). https://doi.org/10.1007/s00535-022-01927-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-022-01927-y